It has been an incredible 8 years of journey with MedGenome and I am grateful to my colleagues and team mates who have been part of this journey with me. Over the last few years, we have expanded the organisation manifolds with respect to clients, customers, team, technology and various associations and tie ups.
Even amidst the pandemic, it was due to our commitment, quality, and knowledge, that we were able to secure generous funding. We even initiated strategic tie ups in the infectious disease segment such as Covid-19 and TB to fight the battle against these diseases. We also have been part of many intriguing researches including the latest being use of Polygenic Risk Score technique for diagnosing cardiac diseases, which received international recognition.
Our role in diagnostic genetic testing touches the life of every patient and is extremely time sensitive. Hence it was important that we continue with our services in the same manner even during the covid times. I am overwhelmed with the support and contribution received from each team member to ensure smooth coordination, quality work and timely results.
I hope with our team strength, intellectual capabilities, quality control and dedication, we will be able to overcome this current situation, grow higher, touch many more lives and be a part of many impactful research projects.
Wishing the best of things to come. Cheers - Ram
Study on Indian Population Identifies 10 Unique Genetic Mutations That Increase Risk of Premature CAD
MedGenome received the ICMR approval for RT-PCR testing for COVID-19 In partnership with XCyton Diagnostics and Narayana Nethralaya, Bengaluru